ArticleJournal of cancer research and clinical oncology2023

Real-world treatment outcomes of carfilzomib plus dexamethasone in patients with relapsed and/or refractory multiple myeloma, focusing on the impact of trial-fitness: CAtholic REsearch network for Multiple Myeloma study (CAREMM-2203).

Sung-Soo Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.